Are bacteriophages the new antibiotics?
Bacteriophages, viruses that infect bacteria, may be used as an alternative treatment option when antibiotics fail. Leiden researchers have studied the structure and function of a novel bacteriophage that could be used to treat one of the WHO bacterial strains of concern where new treatments are urgently needed.
A team of Leiden scientists has been researching a bacteriophage that can fight a specific bacterium. The bacterium in question normally resides in our digestive tract and can cause damage if it spreads to other parts of our body. It can then cause various infections, such as pneumonia and urinary infections.
Phage therapy as an alternative to antibiotics
Ariane Briegel (Institute Biology Leiden) and Daan Pelt (Leiden Institute of Advanced Computer Sciences) tell more about the research. 'According to the WHO, the bacterium raises concern, because it is increasingly resistant to antibiotics. Phage therapy is a potential alternative to fight bacterial infections when antibiotics are not effective,' says Briegel.
That is why it was important for the team to investigate the bacteriophage. Briegel: 'We found out more about the structure and function of the bacteriophage, giving us more insight into how the bacteriophage can infect the pathogen.'
Pelt mapped a part of the bacteriophage by using a neural network, an algorithm that learns from examples. 'At the tip of the bacteriophage is a complex network of tails that play a role in infecting the bacteria. As of yet, little is known about what these tails look like, because there is a large variety in their structures. PhD student Ruochen Ouyang manually mapped seven of these tail structures. We then trained a neural network on the seven examples, so that we can also distinguish the tail structures for other phages,' says Pelt.
'Working together gave us unique insights'
'The collaboration of different disciplines allowed us to get a good insight into various topics,' says Briegel. 'For example, we looked at which structural components the bacteriophage is made up of. We were supported by a team of experts on bacteriophage tail fibres. Because we collaborated with scientists from different backgrounds, we got unique insights about the bacteriophage. This will hopefully help us answer a large spectrum of biological questions in the future.'
The researchers are enthusiastic about this specific bacteriophage. Briegel: 'The problem with phage therapy is that bacteriophages don't work on all bacteria, even from the same species. In contrast to many known bacteriophages, this one is special because it works on many different subtypes. This makes it a good candidate for phage therapy. By learning more about how the bacteriophage works, we can hopefully treat people with it in the future'.
Read the publication of the study here
The paper High resolution reconstruction of a Jumbo bacteriophage infecting capsulated bacteria using hyperbranched tail fibres is published in the scientific journal Nature Communications. From Leiden University, researchers from Leiden Institute of Advanced Computer Science (LIACS) and Institute Biology Leiden (IBL) were part of the research group. Other researchers were from Delft University of Technology, Xi'an Jiaotong University, University of Oxford, University of Wroclaw, Ghent University and University of Warwick.